Fabry disease is a rare inherited disorder caused by changes in the GLA gene, which affects the body’s ability to produce an enzyme called alpha galactosidase A. Reduced enzyme activity can lead to the buildup of a fatty substance called globotriaosylceramide in cells and tissues. The condition may affect the kidneys.
Fabry disease develops because of a disease-causing change, or variant, in the GLA gene. The gene is located on the X chromosome. Since males typically have one X chromosome, a pathogenic GLA variant on that chromosome can result in reduced or absent alpha galactosidase A activity. Females typically have two X chromosomes, so the effects of a GLA variant can vary depending on X chromosome inactivation and other biological factors.
Important genetic considerations include:
Because Fabry disease can be inherited, identifying a pathogenic GLA variant in one family member may have implications for biological relatives.
The primary risk factor for Fabry disease is having a pathogenic variant in the GLA gene. Unlike many common diseases, lifestyle factors such as diet, exercise, or smoking do not cause Fabry disease. A person's genetic background and family inheritance are central to determining whether they have the condition.
Several factors can increase the likelihood that someone may have an inherited GLA variant:
Genetic counseling can help families understand inheritance patterns and discuss appropriate testing. Diagnosis may involve genetic testing, enzyme activity testing, clinical assessment, and evaluation of relevant organs. Testing approaches can differ between males and females.
Fabry disease can sometimes remain unrecognized for years because symptoms overlap with those of other conditions. Recognizing the genetic basis of the disorder and considering family history can therefore be important when appropriate clinical findings are present.
Fabry disease is primarily caused by pathogenic variants in the GLA gene, which lead to reduced activity of alpha galactosidase A and accumulation of certain fatty substances in cells. Its X linked inheritance pattern means that males and females can experience the condition differently. A family history of Fabry disease or a known GLA variant may indicate a need for genetic evaluation of relatives. Understanding these causes and risk factors provides useful information for recognizing inherited patterns and discussing appropriate testing with qualified healthcare professionals.